GYRE stock news · Gyre Therapeutics, Inc.
Get alerts for GYRE
Follow Gyre Therapeutics, Inc. (GYRE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GYREFree on the App Store and Google Play, or on the web.
Gyre Therapeutics shared its financial results for the third quarter of 2026.
NeutralGYRE released results for the 3 and 9 months ended September 30, 2026, but the supplied text gives no figures. It does not show a clear change in the company's outlook.
Gyre Therapeutics has hired Thomas Eastling to be its new Chief Financial Officer.
NeutralGyre named Thomas Eastling as CFO. The filing gives no results or plans, so the appointment alone does not change the company's outlook.
Gyre Therapeutics has hired Ying Luo to be its new CEO.
NeutralGyre Therapeutics appointed Ying Luo as CEO under an employment agreement. The filing gives no details about business changes, so this news does not change the company's outlook.